http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SI-2585051-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_207c148d0cfc11d05383db5abcce58d3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 2011-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab581f746fba14aee415dfc686a16149
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_826b0af303ac0bad09d8a449b68a9741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37abbab01556caaf786cffc54d4023c5
publicationDate 2017-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SI-2585051-T1
titleOfInvention Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
priorityDate 2010-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502131

Total number of triples: 24.